Gladius Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Gladius Capital Management's LLY Position: Q1 2026 in Review
Gladius Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 3,400 shares worth $3.13M. The stake represents 0.14% of the portfolio and ranks #81 among its holdings. This is a return to the name: Gladius Capital Management previously reported a position in LLY as recently as Q3 2025.
Gladius Capital Management first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $6.09M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Gladius Capital Management held 3,400 shares of Eli Lilly worth $3.13M as of Q1 2026.
- Eli Lilly was a new Gladius Capital Management position in Q1 2026.
- Eli Lilly made up 0.14% of Gladius Capital Management's portfolio in Q1 2026, its #81 holding.
- Gladius Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
- Gladius Capital Management's Eli Lilly position peaked at $6.09M in Q4 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.